Overview
Alex is a highly experienced systematic reviewer and information specialist who joined PenTAG as a Research Fellow in September 2023.
He began working in systematic reviews and health technology assessments of research evidence in healthcare in 2011 and has primarily spent the intervening years producing guidelines on behalf of the National Institute of Health and Care Excellence (NICE) and for specialist NHS services.
Alex’s current role in PenTAG is to evaluate health technologies for national policymakers.
Qualifications
- MSc Library and Information Studies (City University, 2010)
- BSc Environmental Science (University of Sussex, 2001)
Research
Research interests
In Alex’s current role, he appraises manufacturer evidence submissions in the Single Technology Appraisal process and these commonly utilise real-world data. His research interests are in systematic review conduct and methodology given the increased use of real-world data.
Research projects
- NICE HTA: Vamorolone for treating inflammation associated with Duchenne muscular dystrophy
- NICE HTA: Ruxolitinib for treating non-segmental vitiligo in people 12 years and over
Publications
Key publications | Publications by category | Publications by year
Publications by category
Journal articles
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, et al (2024). British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine.
Rheumatology (Oxford),
63(2), e37-e38.
Author URL.
Schreiber K, Frishman M, Russell MD, Dey M, Flint J, Allen A, Crossley A, Gayed M, Hodson K, Khamashta M, et al (2023). Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.
Rheumatology (Oxford),
62(4), 1388-1397.
Author URL.
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, et al (2023). Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.
Rheumatology (Oxford),
62(4), 1370-1387.
Author URL.
Publications by year
2024
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, et al (2024). British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine.
Rheumatology (Oxford),
63(2), e37-e38.
Author URL.
2023
Schreiber K, Frishman M, Russell MD, Dey M, Flint J, Allen A, Crossley A, Gayed M, Hodson K, Khamashta M, et al (2023). Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.
Rheumatology (Oxford),
62(4), 1388-1397.
Author URL.
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, et al (2023). Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.
Rheumatology (Oxford),
62(4), 1370-1387.
Author URL.
Refresh publications